Clinical trial
Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis
NCT01425853 is registered in ClinicalTrials.gov with Bioiberica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis
- Lead sponsor
- Bioiberica
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- May 31, 2013
- Enrollment
- 606 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis